Expression of CD45, the pan-leukocyte marker, was higher in Trp53−/− Brca1−/− tumours compared to both the Trp53−/− Brca2−/− and the Brca-proficient Trp53−/− models (Fig. 6A). Here, PTPRC is linked to neoplasm.